DT-101
/ Draig Therapeutics
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 25, 2025
Tarian-1: A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
(clinicaltrials.gov)
- P2 | N=300 | Recruiting | Sponsor: Draig Therapeutics Ltd
New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
1 to 1
Of
1
Go to page
1